Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06793982 · ClinicalTrials.gov registry record · Phase 4
Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain
A Phase 4 study of Hip Osteoarthritis, sponsored by LifeBridge Health.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT06793982: Recruiting Phase 4 study of Hip Osteoarthritis, sponsored by LifeBridge Health.
NCT06793982 is a Phase 4 study of Hip Osteoarthritis that is actively recruiting participants, run by LifeBridge Health. The registered enrollment target is 54 participants, below the 400-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06793982, a Phase 4 study of Hip Osteoarthritis, is actively recruiting participants, sponsored by LifeBridge Health.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.
Primary Outcome
Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10 cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Pain intensity that is calculated by measuring the distance from the "no pain" end of a line to a mark placed by the patient to indicate their current pain level. This will be measured at baseline, six weeks, and three months.
Conditions Studied
Interventions
- DRUG Corticosteroid Injection
- DEVICE Platelet Rich Plasma Joint Injection
Study Locations (1)
Maryland
- Sinai Hospital of Baltimore - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2025-12-01 |
| Phase | Phase 4 |
What NCT06793982 shows while recruiting
NCT06793982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 400-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Hip Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid Injection is the first listed.
NCT06793982 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06793982 about?
NCT06793982 is a clinical study titled "Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain". Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient re...
What is the current status of trial NCT06793982?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2024-02-21. Estimated completion is 2025-12-01.
What conditions does trial NCT06793982 study?
This clinical trial studies the following conditions: Hip Osteoarthritis.
What interventions are being tested in trial NCT06793982?
The interventions under investigation include: Corticosteroid Injection (DRUG), Platelet Rich Plasma Joint Injection (DEVICE).
Who is sponsoring clinical trial NCT06793982?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06793982 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06793982's enrollment target sits among peer trials
54 12th of 11 the lowest of 11 other Hip Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Pericapsular Nerve Block in Total Hip Arthroplasty
RECRUITING · Phase 4
-
Restoration Anatomic Acetabular Shell Revision Study
RECRUITING · NA
-
General vs Spinal in Total Joint Arthroplasty (TJA)
RECRUITING · NA
-
Return to Golf After Orthopaedic Surgery
RECRUITING
-
Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness
RECRUITING · NA
-
Influence of Antiseptic Washes on Wound Healing Complications After THA
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI